// App-Quantinova.ai

65 : Romiplostim in Patients Undergoing Allogeneic Stem Cell Transplantation: Results of a Phase I/II Multicenter Trial

Researchers

Presenter

  • Regis Peffault de Latour

Principal Investigators

  • Sylvie Chevret

  • Annalisa Ruggeri

  • Gerard Socie

  • Felipe Suarez

  • Laetitia Souchet

  • David Michonneau

  • Flore Sicre de Fontbrune

  • Tereza Coman

  • Marie T Rubio

  • Stephanie Nguyen

  • Mohamad Mohty

Medical Centers

  • Hematology Department, CHRU de Nancy, Hopitaux de Brabois, Universite de Lorraine, Nancy, France

  • Department of Haematology, EBMT Paris study office / CEREST-TC / Saint Antoine Hospital, Paris, France

  • Aphp Saint-Louis Hospital, Paris, France

  • Paris Descartes University, Paris, France

  • AP-HP, Hematologie Clinique et Therapie Cellulaire, Hopital Saint-Antoine, Paris, France,

  • Hematology and Bone Marrow Transplantation, Saint-Louis Hospital, Paris, France,

  • AP-HP Hopital Universitaire Necker Enfants Malades, Paris, France

  • Hematology, Hopital Pitie-Salptriere, Paris, France

  • Groupe Hospitalier Pitie-Salpetriere, Assistance Publique-Hopitaux de Paris, Paris, France

  • biostatistics Saint Louis Hospital, paris, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Graft-versus-host disease

  • Alpha-thalassemia myelodysplasia syndrome

  • Venous thrombosis

Biomarkers

  • Creatinine

Drug/Treatment

  • Romiplostim

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I/II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved